全文获取类型
收费全文 | 8324篇 |
免费 | 25篇 |
国内免费 | 5篇 |
专业分类
耳鼻咽喉 | 37篇 |
儿科学 | 1029篇 |
妇产科学 | 315篇 |
基础医学 | 669篇 |
口腔科学 | 267篇 |
临床医学 | 309篇 |
内科学 | 1936篇 |
皮肤病学 | 300篇 |
神经病学 | 289篇 |
特种医学 | 210篇 |
外科学 | 2051篇 |
综合类 | 35篇 |
预防医学 | 188篇 |
眼科学 | 208篇 |
药学 | 254篇 |
中国医学 | 49篇 |
肿瘤学 | 208篇 |
出版年
2023年 | 14篇 |
2022年 | 10篇 |
2021年 | 139篇 |
2020年 | 14篇 |
2019年 | 1159篇 |
2018年 | 901篇 |
2017年 | 505篇 |
2016年 | 8篇 |
2015年 | 16篇 |
2014年 | 45篇 |
2013年 | 38篇 |
2012年 | 20篇 |
2011年 | 31篇 |
2010年 | 23篇 |
2009年 | 34篇 |
2008年 | 19篇 |
2007年 | 24篇 |
2006年 | 27篇 |
2005年 | 24篇 |
2004年 | 24篇 |
2003年 | 15篇 |
2002年 | 19篇 |
2001年 | 18篇 |
2000年 | 20篇 |
1999年 | 20篇 |
1998年 | 13篇 |
1997年 | 14篇 |
1996年 | 6篇 |
1995年 | 4篇 |
1994年 | 5篇 |
1993年 | 3篇 |
1991年 | 5篇 |
1989年 | 3篇 |
1988年 | 2篇 |
1987年 | 2篇 |
1986年 | 4篇 |
1985年 | 438篇 |
1984年 | 632篇 |
1983年 | 326篇 |
1982年 | 512篇 |
1981年 | 427篇 |
1980年 | 356篇 |
1979年 | 409篇 |
1978年 | 329篇 |
1977年 | 341篇 |
1976年 | 403篇 |
1975年 | 340篇 |
1974年 | 301篇 |
1973年 | 303篇 |
1972年 | 4篇 |
排序方式: 共有8354条查询结果,搜索用时 922 毫秒
111.
Jennifer L. Reed Anna E. Clarke Ali M. Faraz David H. Birnie Heather E. Tulloch Robert D. Reid Andrew L. Pipe 《The Canadian journal of cardiology》2018,34(11):1512-1521
Background
Patients with atrial fibrillation (AF) experience symptom burden, exercise intolerance, weight gain, poor mental health, and diminished quality of life (QoL). Cardiac rehabilitation (CR) is recommended for patients with heart disease, and its benefits are well established, yet clinical guidelines for patients with AF do not include the referral to CR.Methods
In this matched retrospective, case-control study, we examined the impact of CR on changes in QoL, mental health, and cardiometabolic health indicators in patients with or without persistent or permanent AF. Patients attended CR that addressed risk factor management and provided support services and exercise training twice weekly for 3 months. Height, body mass, waist circumference, blood pressure, and heart rate were measured, and the Short Form-36 and Hospital Anxiety and Depression Scale were administered at baseline and 3 months follow-up.Results
A total of 94 patients (AF, n = 47; no AF, n = 47) (aged 70 ± 8 years) participated. Significant improvements in 2 of the 8 subscales and the Physical Component Summary of the Short Form-36 were observed across groups after CR (P < 0.05). Significant interactions revealed that the effect of CR was greater for energy, emotional well-being, social functioning, pain, and the Physical Component Summary in patients without AF (P < 0.05 for each). No significant improvements in anxiety (AF: ?1.3 ± 3.4; no AF: ?1.3 ± 4.3), depression (AF: ?1.1 ± 2.9; no AF: ?0.4 ± 2.7), body mass index (AF: ?0.5 ± 1.2; no AF: ?0.8 ± 1.5, kg/m2), waist circumference (AF: ?1.7 ± 4.6; no AF: 0.4 ± 8.1, cm), or blood pressure (AF: ?2.3 ± 17.1/?3.9 ± /9.3; no AF: 1.8 ± 16.4/?0.8 ± /9.3 mm Hg) were observed across groups after CR.Conclusions
CR improved QoL to a greater extent in patients with heart disease without than with persistent or permanent AF. 相似文献112.
Victor J. Dzau 《American heart journal》1988,116(6):1725-1728
Any alteration in the balance between serum lipids, platelets, hemodynamic factors, and the blood vessel wall may lead to the development of atherosclerosis. Hypertension and hypercholesterolemia are two major risk factors that accelerate the development of coronary heart disease. The mechanisms of the interactions of these two risk factors are examined in this paper. First, hypertension may be associated with focal or generalized endothelial injury or dysfunction. The altered endothelial functional integrity may predispose to platelet aggregation and altered vessel wall interaction, which may stimulate proliferation and growth of vascular cells. Second, elevated serum cholesterol levels may accelerate lipid deposition and formation of atherosclerotic plaques. In hypertension the rate of clearance of lipoprotein from the vessel wall may be reduced. Third, the sympathetic nervous system may be involved in both the development of hypertension and the alterations of lipid metabolism. Adrenergic activation, which increases blood pressure may also adversely affect lipid metabolism. This is in part α1-adrenoceptor mediated. Selective α1-inhibitors have been found to prevent or reduce atherosclerosis in experimental animals. Selective α1-inhibitors may act at a number of sites on lipoprotein metabolic pathways to favorably influence serum lipids. Taken together, the relationship between hypertension and atherosclerosis involves complex mechanisms. A complete understanding of the mechanisms is of obvious importance. 相似文献
113.
Tetsuro Sugiura Yoshinori L Doi Bruce G. Haffty Kathleen A. Moreau Richard L. Bishop Jang B. Singh David H. Spodick 《The American journal of cardiology》1981,48(1):101-105
Among 738 consecutive patients with chest pain referred for exercise testing, only 17 men fulfilled strict criteria for this pilot study: (1) achievement of at least 90 percent of age-predicted maximal heart rate or etectrocardtographic criteria for a positive test; (2) subsequent coronary anglography; (3) exclusion of prior heart disease; and (4) absence of medication. Measurements of systolic time intervals obtained with ear densitography during early exercise differentiated 10 patients with coronary artery disease (Group 1) from 17 men (7 patients plus 10 normal volunteers) with normal coronary arteries (Group 2). Despite nearly identical heart rate and blood pressure responses In both groups, men In Group 1 had a significantly greater reduction of preelection period (PEP) at 1 minute and 4 minutes as well as a greater decrease hi PEP/LVET (left ventricular ejection time) ratio. Differences were most significant when expressed as percent change of ratio from control value (p <0.001 at both 1 minute and 4 minutes). After 4 minutes, men in Group 1 had no further decrease in ratio and in 8 of the 10 men ratio then increased to peak exercise. By contrast, ratio continued to decrease to peak exercise in men In Group 2. The early floor in ratio In Group 1 represents limited functional reserve and the subsequent increase suggests functional deterioration. Thus, densHographic systolic time interval measurements during uninterrupted exercise in unmedlcated subjects appear to improve the sensitivity and specificity of the conventional treadmill test. 相似文献
114.
G Wisenberg A G Zawadowski V A Gebhardt F S Prato M D Goddard P M Nichol P A Rechnitzer 《Journal of the American College of Cardiology》1985,6(1):84-92
As an agent potentially capable of inducing ischemia in patients with coronary artery disease, dopamine administered intravenously was evaluated as a pharmacologic stress agent by supine radionuclide angiography, and the results were compared with ergometer exercise. In a preliminary group of 11 subjects (4 normal subjects and 7 patients with coronary disease), dopamine alone was administered in increments of 2.5 micrograms/kg per min to a maximum of 15 micrograms/kg per min. There were significant differences between exercise and dopamine in maximal stress heart rates, 129.3 +/- 30.0 versus 88.0 +/- 35.8 beats/min (p less than 0.05) in normal subjects and 118.9 +/- 21.1 versus 87.6 +/- 22.6 beats/min (p less than 0.05) in patients with coronary disease, as well as in maximal stress rate-pressure products, 213.3 +/- 51.4 versus 155.0 +/- 52.5 mm Hg/min X 10(2) (p less than 0.02) in normal subjects and 216.0 +/- 45.6 versus 161.0 +/- 48.6 mm Hg/min X 10(2) (p less than 0.003) in patients with coronary disease. As a result, in these patients the ejection fraction response was significantly different: -3.3 +/- 4.5% with exercise versus + 6.3 +/- 4.6% with dopamine (p less than 0.05). In a second group of 41 subjects (9 normal subjects and 32 patients with coronary disease), atropine (0.6 mg) was administered intravenously before and after every second dopamine dose increment. This produced statistically similar maximal stress heart rates as compared with exercise in all subjects, rate-pressure products in normal subjects and slightly higher values with dopamine in patients with coronary disease: 200.3 +/- 47.2 versus 183.1 +/- 43.0 (p less than 0.05).(ABSTRACT TRUNCATED AT 250 WORDS) 相似文献
115.
Cameron J.B. Cunningham Heather C. Finlayson William R. Henderson Russell J. O’Connor Andrew Travlos 《PM & R》2018,10(5):494-500
Background
Critical illness polyneuromyopathy (CIPNM) increasingly is recognized as a source of disability in patients requiring intensive care unit (ICU) admission. The prevalence and impact of CIPNM on patients in the rehabilitation setting has not been established.Objectives
To determine the proportion of at-risk rehabilitation inpatients with evidence of CIPNM and the functional sequelae of this disorder.Design
Prospective observational study.Setting
Tertiary academic rehabilitation hospital.Patients
Rehabilitation inpatients with a history of ICU admission for at least 72 hours.Methods
Electrodiagnostic studies were performed to evaluate for axonal neuropathy and/or myopathy in at least one upper and one lower limb.Main Outcome Measurements
The primary outcome was prevalence of CIPNM. Secondary outcomes included Functional Independence Measure (FIM) scores, rehabilitation length of stay (RLOS), and discharge disposition.Results
A total of 33 participants were enrolled; 70% had evidence of CIPNM. Admission FIM score, discharge FIM, FIM gain, and FIM efficiency were 64.1, 89.9, 25.5, and 0.31 in those with CIPNM versus 78.4, 94.6, 16.1, and 0.33 in those without CIPNM, respectively. Average RLOS was 123 days versus 76 days and discharge to home was 57% versus 90% in the CIPNM and non-CIPNM groups, respectively.Conclusions
CIPNM is very common in rehabilitation inpatients with a history of ICU admission. It was associated with a lower functional status at rehabilitation admission, but functional improvement was at a similar rate to those without CIPNM. Longer RLOS stay may be required to achieve the same functional level.Level of Evidence
III 相似文献116.
117.
118.
119.
Neal I. Lindeman Philip T. Cagle Dara L. Aisner Maria E. Arcila Mary Beth Beasley Eric H. Bernicker Carol Colasacco Sanja Dacic Fred R. Hirsch Keith Kerr David J. Kwiatkowski Marc Ladanyi Jan A. Nowak Lynette Sholl Robyn Temple-Smolkin Benjamin Solomon Lesley H. Souter Erik Thunnissen Yasushi Yatabe 《The Journal of molecular diagnostics : JMD》2018,20(2):129-159
120.